Parnassus Investments LLC decreased its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,796,979 shares of the company's stock after selling 6,740 shares during the quarter. Parnassus Investments LLC owned 0.16% of Procter & Gamble worth $657,637,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the company. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Procter & Gamble in the third quarter valued at approximately $301,950,000. SouthState Corp raised its holdings in Procter & Gamble by 0.4% during the third quarter. SouthState Corp now owns 78,995 shares of the company's stock worth $13,682,000 after purchasing an additional 289 shares in the last quarter. Guardian Wealth Advisors LLC raised its holdings in Procter & Gamble by 2.5% during the third quarter. Guardian Wealth Advisors LLC now owns 4,049 shares of the company's stock worth $701,000 after purchasing an additional 99 shares in the last quarter. Fifth Third Wealth Advisors LLC raised its holdings in Procter & Gamble by 8.5% during the third quarter. Fifth Third Wealth Advisors LLC now owns 37,479 shares of the company's stock worth $6,491,000 after purchasing an additional 2,937 shares in the last quarter. Finally, Wrapmanager Inc. raised its holdings in Procter & Gamble by 9.0% during the third quarter. Wrapmanager Inc. now owns 11,274 shares of the company's stock worth $1,953,000 after purchasing an additional 932 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Insiders Place Their Bets
In related news, COO Shailesh Jejurikar sold 14,034 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $169.78, for a total value of $2,382,692.52. Following the sale, the chief operating officer now directly owns 9,856 shares in the company, valued at $1,673,351.68. The trade was a 58.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the sale, the chief executive officer now owns 13,721 shares in the company, valued at $2,332,570. This represents a 87.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 270,727 shares of company stock worth $46,014,037. Corporate insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on PG. Morgan Stanley raised their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a report on Monday, October 21st. DA Davidson raised their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a "neutral" rating in a report on Monday, October 21st. DZ Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price objective on the stock in a report on Thursday, August 29th. Stifel Nicolaus raised their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a "hold" rating in a report on Monday, July 22nd. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $177.00.
Check Out Our Latest Research Report on Procter & Gamble
Procter & Gamble Stock Performance
NYSE:PG opened at $170.80 on Tuesday. The firm's fifty day moving average price is $170.21 and its 200 day moving average price is $168.45. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market cap of $402.24 billion, a price-to-earnings ratio of 29.45, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business's revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 EPS. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.36%. Procter & Gamble's payout ratio is currently 69.48%.
Procter & Gamble Company Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.